4th AI Drug Discovery Competition Finals
Ministry of Health and Welfare / Korea Health Industry Development Institute; Korea University College of Medicine; BK21 Education and Research Group; Korea Pharmaceutical and Bio-Pharma Manufacturers Association
Overview
Provides the schedule, entry conditions, submission requirements and checked sources.
Implement an Agentic AI service related to drug discovery.
Restrictions on tools other than the supported APIs have not been confirmed.
Notice dates
- Notice closing date
- 2026-10-02
Calendar dates from the saved notice. They do not establish a deadline time, time zone or current acceptance status.
Eligibility
Only individuals or teams that qualified through the preliminary round of the 4th AI Drug Discovery Competition may enter the final; no new general entries.
Finalist-selection eligibility is the first condition.
Initial qualifying-round details, including company-name entries and team-size limits, are unverified.
Deliverables
For the drug-discovery Agent: a working demo URL and run instructions, a research/technical report, and presentation materials.
Approx.
10-minute YouTube demo submitted as unlisted (not public)
Presentation PDF for 5–10 minutes, including Agent performance metrics and evaluation criteria
Cautions and verification notes
Automatic registration of finalists does not mean that the user has actually completed an application.
The awards ceremony dates conflict: 11/26–27 in the detailed table and 11/16 in the schedule at the bottom.
Distinguish the guidance on awards for approximately 10 teams from the overlapping-award conditions for the sponsor awards covering 7 teams.
Participation fees, excess API costs, and IP details are unconfirmed.
Sources
Check the original notice for current rules. English includes editorial renderings of stored notices and organizer names, not verified official English names. Original records are preserved. Excerpts may be incomplete; consult the linked sources for full conditions.